All the
latest

March 21, 2023

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of non-qualified stock options to purchase an

Read more
March 14, 2023

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

Dr. Camille Bedrosian to continue employment as strategic development advisor with the company NOVATO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that Eric Crombez, M.D., has been promoted to chief medical officer and executive vice president

Read more

Upcoming events & latest presentations

March 21-22, 2023

Gene Therapy for Rare Disorders Summit
Speakers included: Eric Crombez, M.D. and Jessica Riviere

Register for this event
Ultragenyx Presentation at J.P. Morgan 2023 Healthcare Conference

Presentation at J.P. Morgan 2023 Healthcare Conference

Download
Ultragenyx Corporate Presentation

Corporate Presentation

Download